Posts

Tom Essaye Quoted in CNBC on September 10, 2020

“Hopes for a stimulus deal before the election (Nov 3rd) are fading, and if that’s the case we should expect that to weigh on stocks in the coming weeks…” Tom Essaye, founder of The Sevens Report. Click here to read the full article.

Trader on the Stock Exchange floor

Tom Essaye Quoted in Unseen Opportunity on September 3, 2020

“Let me be clear: The only reason we do not have a stimulus bill passed yet is because the economy and…” explained Tom Essaye, founder of The Sevens Report. Click here to read the full article.

Tom Essaye Quoted in CNBC on September 2, 2020

“Let me be clear: The only reason we do not have a stimulus bill passed yet is because the economy and the markets are performing…” said Tom Essaye, founder of The Sevens Report. Click here to read the full article.

Tom Essaye Quoted in Yahoo Finance on September 1, 2020

“Once different industry participants start sending people out to the field again and visiting customers, everyone else will follow. Zoom is a…” said Sevens Report Research founder Tom Essaye. Click here to read the full article.

Tom Essaye Quoted in Barron’s on August 28, 2020

“Now, over the medium and long term, the Fed’s average inflation target means that when cyclicals start to outperform, and when yields begin to rise, both those rallies will last longer…” writes Tom Essaye of The Sevens Report newsletter. Click here to read the full article.

Tom Essaye Quoted in Positively Scottish Scot on August 24, 2020

“What does that mean for us? It usually means remain long stocks in more time-dated accounts, and make confident you…” Sevens Report Study founder Tom Essaye recently spelled out to Yahoo Finance. Click here to read the full article.

Warren Buffett

Tom Essaye Quoted in MarketWatch on August 24, 2020

“What does that mean for us? It means stay long stocks in longer-dated accounts, and make sure…” Sevens Report Research founder Tom Essaye recently explained to Yahoo Finance.

Warren Buffett

Tom Essaye Quoted in Forbes on August 24, 2020

“While the early use authorization for plasma is clearly a positive, from a market standpoint a vaccine remains a true…” says Tom Essaye, editor of the Sevens Report. Click here to read the full article.

Tom Essaye Quoted in Barron’s on August 24, 2020

”Futures are moderately higher on Covid-19 treatment optimism following the FDA’s authorization of plasma treatment…” wrote The Sevens Report’s Tom Essaye before the open. Click here to read the full article.

Tom Essaye Interviewed with TD Ameritrade Network on August 24, 2020

Tom Essaye interviewed with Ben Lichtenstein from TD Ameritrade Network to discuss consumer-oriented earnings, treasury, stocks, and more…Click here to watch the full interview.